Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
74 hedge funds and large institutions have $63.1M invested in Avid Bioservices, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 7 closing their positions.
138% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 13
74% more capital invested
Capital invested by funds: $36.3M → $63.1M (+$26.8M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
46% more call options, than puts
Call options by funds: $730K | Put options by funds: $501K
6% more funds holding
Funds holding: 70 → 74 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.2M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$1.08M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.08M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.07M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$937K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$264K |
| 3 |
Renaissance Technologies
New York
|
-$132K |
| 4 |
Millennium Management
New York
|
-$108K |
| 5 |
Citigroup
New York
|
-$106K |
CDMO Hedge Fund Activity: Q1 2014 in Review
74 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q1 2014, worth a combined $63.1M — up 74% from $36.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CDMO positions and 7 closed out — a net gain of 4 holders — while 31 added to existing stakes and 13 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.2M. The largest seller was Schroder Investment Management Group, cutting an estimated $937K.
- 74 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q1 2014, up from 70 in Q4 2013.
- Funds reported $63.1M of Avid Bioservices, Inc. Common Stock stock for Q1 2014, up 74% quarter-over-quarter.
- 11 funds opened new Avid Bioservices, Inc. Common Stock positions in Q1 2014 and 7 closed out, a net change of +4 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q1 2014 was Sphera Funds Management, an estimated $1.2M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q1 2014 was Schroder Investment Management Group, an estimated $937K sold.
Based on aggregated 13F filings for Q1 2014.